Health ❯Healthcare ❯Clinical Trials
Combination Therapy Alzheimer's Treatments Targeted Therapy Phase III Trials Phase 2 Trials Eli Lilly Azelaprag Lenacapavir Oral Medications Targeted Therapies
This approach marks the first reversal of early neuronal damage in genetic Parkinson’s models, pointing toward disease-modifying therapies.